Edwards Lifesciences EW Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Europe | $1.62B+21.0% | $1.52B+14.8% | $1.45B+13.4% | $1.38B+11.3% | $1.34B+10.3% | |
| Japan | $363.5M+8.3% | $354.7M+4.4% | $353.1M0.0% | $344.4M-3.4% | $335.6M-6.2% | |
| Rest of World | $679.9M+15.9% | $652.3M+14.0% | $630.1M+12.4% | $611.1M+11.5% | $586.4M+8.0% | |
| United States | $3.64B+11.6% | $3.54B+10.5% | $3.45B+9.9% | $3.35B+9.0% | $3.26B+7.9% | |
| Net Sales by Product | ||||||
| Transcatheter Aortic Valve Replacement | $4.64B+11.9% | $4.49B+9.3% | $4.36B+7.8% | $4.24B+6.3% | $4.14B+5.2% | |
| Transcatheter Mitral and Tricuspid Therapies | $610.5M+54.8% | $550.6M+56.4% | $500M+65.0% | $445.9M+68.7% | $394.4M+72.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Edwards Lifesciences break its business down?
- Edwards Lifesciences (EW) reports net sales by business across 4 parts — Europe, Japan, Rest of World and United States. Each is extracted from the segment footnotes and tracked over time.
- Where does Edwards Lifesciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Edwards Lifesciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
